New HIV vaccine shows unprecedented success in preclinical study
|
Scientists at La Jolla Institute for Immunology, Scripps
Research have developed an HIV vaccine that trains immune cells to see
past HIV's defenses. |
South Africa moves to eliminate HIV threat with Lenacapavir rollout
Making the HIV prevention medicine available to South Africans was one of the commitments the President made in the State of the Nation Address (SONA) ... View article...